Angiotensin II Receptor Antagonist Peptides (ARB-peptides)
Also known as: Peptide ARBs, Angiotensin receptor blocker peptides
Peptide-based angiotensin II receptor blockers that regulate blood pressure and reduce cardiovascular inflammation through selective AT1 receptor antagonism.
Beginner Basics
Plain-English guide to Angiotensin II Receptor Antagonist Peptides (ARB-peptides)
What it does
This peptide works like a brake on a specific receptor in your blood vessels that controls blood pressure and inflammation. Researchers study it to help manage high blood pressure and reduce strain on the heart and kidneys.
Typical dose
Researchers typically start at 100 micrograms and may go up to 300 micrograms, injected under the skin once or twice daily.
When to inject
Inject in the morning and/or evening at the same times each day to keep levels consistent in your body.
Storage
Keep the dry powder in a cool, dark place until you mix it. Once mixed with liquid, store in the refrigerator and use within the time specified by your supplier.
First-timer tip
Start at the lower dose (100 mcg) and only increase if needed-this gives your body time to adjust and helps you notice how it affects you.
On This Page
Research Status
Clinical trials
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
May occur especially during initial dosing or dose escalation. Symptoms include dizziness, lightheadedness, or syncope. Manage by rising slowly from sitting or lying positions, increasing fluid intake, and monitoring blood pressure regularly. Inform your healthcare provider if symptoms persist or worsen.
ARB-peptides reduce aldosterone, which can increase serum potassium levels. Risk is higher in patients with renal impairment, diabetes, or concurrent use of ACE inhibitors, NSAIDs, or potassium supplements. Requires periodic serum potassium monitoring. Contact your healthcare provider immediately if you experience muscle weakness, palpitations, or irregular heartbeat.
May cause transient increases in serum creatinine or decreases in glomerular filtration rate (GFR), particularly in patients with pre-existing renal disease or severe bilateral renal artery stenosis. Requires baseline and periodic monitoring of serum creatinine and eGFR. Discontinue if creatinine rises >30% from baseline.
Redness, swelling, bruising, or mild pain at the injection site. Usually resolves within 24-48 hours. Prevent by rotating injection sites, using proper injection technique, and allowing the solution to reach room temperature before injection. Apply ice if swelling occurs.
Localized loss or accumulation of subcutaneous fat at frequently used injection sites. Prevent by systematically rotating injection sites with each dose and spacing injections at least 1 inch apart. This is cosmetic and typically reversible if site rotation is implemented.
Often related to blood pressure reduction. Manage by rising slowly from sitting or lying positions, staying well-hydrated, and avoiding rapid position changes. Usually resolves within 1-2 weeks as the body adjusts.
May occur during initial dosing or dose escalation. Usually self-resolving within 1-2 weeks. If persistent, contact your healthcare provider to rule out hyperkalemia or other causes.
Unlike ACE inhibitors, ARB-peptides should not significantly increase bradykinin levels, so cough is rare. If cough develops, consult your healthcare provider to rule out other causes.
Rare but serious allergic reaction causing swelling of the face, lips, tongue, or throat. Seek immediate emergency medical attention if you experience difficulty breathing, swallowing, or speaking, or if facial swelling develops. Discontinue immediately and do not rechallenge.
Skin rash or hives may indicate hypersensitivity to the peptide or excipients. Discontinue use and contact your healthcare provider. Do not rechallenge without medical supervision.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 100-300 mcg |
Frequency, timing and route - members only | |
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2-8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
ARB-peptides function as selective antagonists of the angiotensin II type 1 (AT1) receptor, blocking the binding of angiotensin II and preventing downstream signaling that leads to vasoconstriction, aldosterone release, and inflammatory responses. By inhibiting AT1 receptor activation, these peptides reduce blood pressure, decrease sodium and water retention, and suppress pro-inflammatory and pro-fibrotic pathways in the cardiovascular and renal systems. This mechanism is similar to small-molecule ARBs but may offer improved selectivity, reduced off-target effects, and potentially enhanced tissue penetration depending on the specific peptide sequence and formulation.
Track your Angiotensin II Receptor Antagonist Peptides (ARB-peptides) research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Angiotensin II Receptor Antagonist Peptides (ARB-peptides) is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.